Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ferric Hydroxide-polymaltose
2. Ferric Polymaltose
3. Ferripolyisomaltose
4. Ferrum Hausmann
5. Intrafer
6. Iron Hydroxide Polymaltose
7. Iron(iii)-hydroxide-dextrin
8. Iron-polymaltose Complex
9. Noripurum
10. Teferrol
1. Ferrummate
2. Amylofer
3. Maltofer
4. Ferripel 3
5. 53858-86-9
6. Um5219h89v
7. Teferrol
8. Ferrum Hausmann
9. Iron(3+);(2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;trihydroxide
10. Injectafer
11. Ferinject
12. Ferripel-3
13. Ferromaltose
14. Unii-um5219h89v
15. Ferric Hydroxide Polymaltose Complex
16. Iron(iii)-hydroxide Polymaltose Complex
17. Ferric Hydroxide Polymaltose Complex [who-dd]
18. Q27291136
1. Iron Hydroxide Oxide Nanoparticles / Nanopowder
2. Iron Hydroxide Oxide
3. Iron Oxide Hydroxide
4. Iron Hydroxide Nanorods
5. Iron Hydroxide Oxide (feo(oh))
6. Iron Oxide Hydroxide, Aqueous Nanoparticle Dispersion, <5 Nm (dls), 20% Solids By Weight, Ph ~3, 99.5% Trace Metals Basis
7. Iron Hydroxide Oxide (fe(oh)o)
Molecular Weight | 449.16 g/mol |
---|---|
Molecular Formula | C12H25FeO14 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 8 |
Exact Mass | 449.059366 g/mol |
Monoisotopic Mass | 449.059366 g/mol |
Topological Polar Surface Area | 200 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 367 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Hematinics
Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33716
Submission : 2019-04-10
Status : Active
Type : II
Date of Issue : 2022-05-04
Valid Till : 2025-07-28
Written Confirmation Number : WC-0449A1
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33717
Submission : 2019-05-07
Status : Active
Type : II
Date of Issue : 2022-05-04
Valid Till : 2025-07-28
Written Confirmation Number : WC-0449A1
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32220
Submission : 2017-10-31
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm :
Date of Issue : 2023-11-15
Valid Till : 2026-11-14
Written Confirmation Number : WC-0573
Address of the Firm :
Polymaltose ferric hydroxide salt
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2022-01-10
Registration Number : 20220110-211-J-1113
Manufacturer Name : BIOFER SPA
Manufacturer Address : Via Canina, 2 - 41036 MEDOLLA (MO), Italy
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Iron III Hydroxide Polymaltose Complex
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of expertise in formulation development, manufacturing, and commercialization. Our portfolio...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Iron III Hydroxide Polymaltose Complex
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Pharm-Rx has earned an outstanding reputation since its establishment in 1991, serving as a reputable importer and distributor of active ingredients to the pharmaceutical, nutritio...
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
Iron III Hydroxide Polymaltose Complex
About the Company : Zeal MediPharma is a globally recognized Star One Export House, serving customers in over 50 countries for more than two decades. We specialize in sourcing and exporting high-quali...
Iron III Hydroxide Polymaltose Complex
About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...
About the Company : As an EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979 as Calcium Ind...
Iron III Hydroxide Polymaltose Complex
About the Company : SHANPAR's commitment to quality, reliability, consistency, and excellence is reflected in its esteemed clientele, which includes leading global companies. With a humble beginning 2...
About the Company : Sudeep Pharma Pvt. Ltd. is a leading producer of Calcium based Pharmaceutical, Food and Feed ingredients in India for the last quarter of a century. Established in 1989, we are one...
Iron III Hydroxide Polymaltose Complex
About the Company : Viyash, true to its name, literally represents honesty and leadership in every sense. We are an integrated pharmaceutical company with a strong portfolio of niche formulations, ...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Iron III Hydroxide Polymaltose Complex
Brand Name : Iron III Hydroxide Polymaltose Complex
Dosage Form : DC Granules
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Iron III Hydroxide Polymaltose Complex; Folic Acid
Brand Name : Iron III Hydroxide Polymaltose Complex; Folic Acid
Dosage Form : Chewable Tablet
Dosage Strength : 100MG; 0.350MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Iron III Hydroxide Polymaltose Complex; Folic Acid
Brand Name : Iron III Hydroxide Polymaltose Complex; Folic Acid
Dosage Form : DC Granules
Dosage Strength : 100MG; 0.350MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Iron III Hydroxide Polymaltose Complex; Folic Acid; Zinc
Brand Name : Iron III Hydroxide Polymaltose Complex; Folic Acid; Zinc
Dosage Form : Chewable Tablet
Dosage Strength : 100MG; 0.350MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Originator
Registration Country : South Africa
Iron(III)-Hydroxide Sucrose Complex
Brand Name : Venofer injection
Dosage Form : INJ
Dosage Strength : 100mg/5ml
Packaging : 5X5mg/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Vietnam
Brand Name : Fogyma
Dosage Form : Oral Solution
Dosage Strength : 50MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
Regulatory Info :
Registration Country : India
Iron III Hydroxide Polymaltose Complex; Folic Acid; Zinc
Brand Name :
Dosage Form : Chewable Tablet
Dosage Strength : 100MG; 0.350MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Iron III Hydroxide Polymaltose Complex
Brand Name :
Dosage Form : DC Granules
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country :
Iron III Hydroxide Polymaltose Complex; Folic Acid
Brand Name : Ferose-F
Dosage Form : Tablet
Dosage Strength : 100MG; 350MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Regulatory Info :
Registration Country : Australia
Brand Name : Ferrosig
Dosage Form : injection
Dosage Strength : 100 mg/2 mL
Packaging : 5
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
46
PharmaCompass offers a list of Iron III Hydroxide Polymaltose Complex API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iron III Hydroxide Polymaltose Complex manufacturer or Iron III Hydroxide Polymaltose Complex supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iron III Hydroxide Polymaltose Complex manufacturer or Iron III Hydroxide Polymaltose Complex supplier.
PharmaCompass also assists you with knowing the Iron III Hydroxide Polymaltose Complex API Price utilized in the formulation of products. Iron III Hydroxide Polymaltose Complex API Price is not always fixed or binding as the Iron III Hydroxide Polymaltose Complex Price is obtained through a variety of data sources. The Iron III Hydroxide Polymaltose Complex Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Iron III Hydroxide Polymaltose Complex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iron III Hydroxide Polymaltose Complex, including repackagers and relabelers. The FDA regulates Iron III Hydroxide Polymaltose Complex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iron III Hydroxide Polymaltose Complex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Iron III Hydroxide Polymaltose Complex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Iron III Hydroxide Polymaltose Complex supplier is an individual or a company that provides Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) or Iron III Hydroxide Polymaltose Complex finished formulations upon request. The Iron III Hydroxide Polymaltose Complex suppliers may include Iron III Hydroxide Polymaltose Complex API manufacturers, exporters, distributors and traders.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Iron III Hydroxide Polymaltose Complex DMF (Drug Master File) is a document detailing the whole manufacturing process of Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) in detail. Different forms of Iron III Hydroxide Polymaltose Complex DMFs exist exist since differing nations have different regulations, such as Iron III Hydroxide Polymaltose Complex USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Iron III Hydroxide Polymaltose Complex DMF submitted to regulatory agencies in the US is known as a USDMF. Iron III Hydroxide Polymaltose Complex USDMF includes data on Iron III Hydroxide Polymaltose Complex's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Iron III Hydroxide Polymaltose Complex USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Iron III Hydroxide Polymaltose Complex Drug Master File in Korea (Iron III Hydroxide Polymaltose Complex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Iron III Hydroxide Polymaltose Complex. The MFDS reviews the Iron III Hydroxide Polymaltose Complex KDMF as part of the drug registration process and uses the information provided in the Iron III Hydroxide Polymaltose Complex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Iron III Hydroxide Polymaltose Complex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Iron III Hydroxide Polymaltose Complex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with KDMF on PharmaCompass.
A Iron III Hydroxide Polymaltose Complex written confirmation (Iron III Hydroxide Polymaltose Complex WC) is an official document issued by a regulatory agency to a Iron III Hydroxide Polymaltose Complex manufacturer, verifying that the manufacturing facility of a Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Iron III Hydroxide Polymaltose Complex APIs or Iron III Hydroxide Polymaltose Complex finished pharmaceutical products to another nation, regulatory agencies frequently require a Iron III Hydroxide Polymaltose Complex WC (written confirmation) as part of the regulatory process.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with Written Confirmation (WC) on PharmaCompass.
Iron III Hydroxide Polymaltose Complex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iron III Hydroxide Polymaltose Complex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iron III Hydroxide Polymaltose Complex GMP manufacturer or Iron III Hydroxide Polymaltose Complex GMP API supplier for your needs.
A Iron III Hydroxide Polymaltose Complex CoA (Certificate of Analysis) is a formal document that attests to Iron III Hydroxide Polymaltose Complex's compliance with Iron III Hydroxide Polymaltose Complex specifications and serves as a tool for batch-level quality control.
Iron III Hydroxide Polymaltose Complex CoA mostly includes findings from lab analyses of a specific batch. For each Iron III Hydroxide Polymaltose Complex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iron III Hydroxide Polymaltose Complex may be tested according to a variety of international standards, such as European Pharmacopoeia (Iron III Hydroxide Polymaltose Complex EP), Iron III Hydroxide Polymaltose Complex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iron III Hydroxide Polymaltose Complex USP).